
Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CC
Member of the Healthcare Council
Adam D. Schaffner, MD, FACS, is an Assistant Professor of Clinical Plastic and Reconstructive Surgery, Georgetown University Medical Center. He has previously served as a Clinical Assistant Professor of Otorhinolaryngology at Weill Cornell Medical College in New York City. He is board certified in otolaryngology as well as board certified and fellowship-trained in facial plastic and reconstructive surgery. Dr. Schaffner has also completed a plastic surgery residency where he served as chief resident. He has served as a faculty member at numerous courses on facial plastic surgery, including three at Stanford. He has co-authored numerous publications. Dr. Schaffner has also served as a consultant for Pfizer, BioForm Medical, Sanofi-Aventis, Kythera Pharmaceuticals, and ABC News. He is listed in Marquis Who's Who in America and Marquis Who's Who in Medicine and Healthcare. (This is me - Update Profile)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Bold Contest for a Daunting Problem
October 27, 2008
Adam Schaffner, Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CC
WellPoint, X Prize launch $10M health care contest | news.yahoo.com
Most people agree that the healthcare system in the United States is in need of a complete overhaul. Unfortunately, the many competing interests in the current system make such overhaul extremely challenging. This contest certainly provides much incentive for the...
Evolence: Will this New "Advanced" Collagen Filler Take Hold?
July 8, 2008
Adam Schaffner, Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CC
FDA Approves EVOLENCE®, a New Generation Collagen-Based Facial Filler | www.investor.jnj.com
Evolence is an injectable filler material that is made by an "advanced collagen GLYMATRIX™ Technology." Collagen has generally fallen out of favor amongst aesthetic physicians due to its short duration of action. Evolence will have to demonstrate that it is superior to the plethora...
Allergan and Aczone: Likely a Winning Combination
June 26, 2008
Adam Schaffner, Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CC
Allergan Aquisition of Aczone | agn360.client.shareholder.com
Allergan has a strong infrastructure to support dermatologic and aesthetic products. Aczone, an aqueous topical gel containing 5% dapsone, will be a new product which will help treat patients with acne. "The strength of topical dapsone gel appears to be its high efficacy against...
Obesity: Higher Healthcare Costs, Lower Productivity
June 26, 2008
Adam Schaffner, Assistant Professor of Clinical Plastic Surgery, Georgetown University Medical Center - CC
Obesity costs employers $45 bil a year | www.nytimes.com
There is no revelation in stating that obese people move slower or have more health problems compared to skinny people. High blood pressure and diabetes are commonly associated with obesity. Morbidly obese people may have difficulty sitting in a single coach airplane seat, fitting through...
| Study Group Name | No. Members |
|---|---|
| Juvederm Users: Cosmetic Dermatologists (US) | 134 |
| Physicians who Treat Chronic Sinusitis (US) | 142 |
| Otolaryngologists (US) | 207 |
| Versatile 1 Pump Users (US) | 60 |
Adam Schaffner has not participated in any GLG Live Meetings.